ATE410185T1 - Oral verabreichbare antimikrobielle zusammensetzung - Google Patents

Oral verabreichbare antimikrobielle zusammensetzung

Info

Publication number
ATE410185T1
ATE410185T1 AT05782960T AT05782960T ATE410185T1 AT E410185 T1 ATE410185 T1 AT E410185T1 AT 05782960 T AT05782960 T AT 05782960T AT 05782960 T AT05782960 T AT 05782960T AT E410185 T1 ATE410185 T1 AT E410185T1
Authority
AT
Austria
Prior art keywords
antimicrobial composition
composition
lactulose
orally administered
antibiotic
Prior art date
Application number
AT05782960T
Other languages
English (en)
Inventor
Nikolai Alexandrovich Kiselev
Dmitry Sergeevich Chicherin
Original Assignee
Nikolai Alexandrovich Kiselev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE410185(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nikolai Alexandrovich Kiselev filed Critical Nikolai Alexandrovich Kiselev
Application granted granted Critical
Publication of ATE410185T1 publication Critical patent/ATE410185T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05782960T 2004-08-30 2005-08-25 Oral verabreichbare antimikrobielle zusammensetzung ATE410185T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения

Publications (1)

Publication Number Publication Date
ATE410185T1 true ATE410185T1 (de) 2008-10-15

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05782960T ATE410185T1 (de) 2004-08-30 2005-08-25 Oral verabreichbare antimikrobielle zusammensetzung

Country Status (21)

Country Link
US (1) US8231871B2 (de)
EP (1) EP1790357B1 (de)
JP (1) JP5062480B2 (de)
CN (1) CN101031321B (de)
AT (1) ATE410185T1 (de)
AU (1) AU2005280704B2 (de)
BR (1) BRPI0514708A (de)
CA (1) CA2620919C (de)
DE (1) DE602005010280D1 (de)
DK (1) DK1790357T3 (de)
EA (1) EA200700357A1 (de)
ES (1) ES2314708T3 (de)
MX (1) MX2007002291A (de)
NZ (1) NZ554212A (de)
PL (1) PL1790357T3 (de)
PT (1) PT1790357E (de)
RU (1) RU2284832C2 (de)
TR (1) TR200703565T1 (de)
UA (1) UA85608C2 (de)
WO (1) WO2006025767A2 (de)
ZA (1) ZA200704449B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103040773A (zh) 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
ES2588584T3 (es) * 2005-01-21 2016-11-03 Warner Chilcott Company, Llc Un complejo metálico de tetraciclina en una forma de dosificación sólida
BRPI0822485A2 (pt) * 2008-03-18 2015-06-16 Aleksander Vladimirovich Dikovskiy Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos.
CN101998858A (zh) 2008-03-18 2011-03-30 亚历山大·弗拉基米罗维奇·季科夫斯基 抗生素和益生元的药物组合物用于预防和治疗抗生素治疗中的微生态失调
US10190153B2 (en) 2013-05-07 2019-01-29 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
EP0169700B1 (de) * 1984-07-23 1990-05-16 Eli Lilly And Company Pharmazeutische Zusammensetzungen von Ceftazidim
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
CA1329805C (en) * 1988-03-18 1994-05-24 Hendrikus W. Weterings Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
ATE226090T1 (de) * 1994-04-22 2002-11-15 Yamanouchi Pharma Co Ltd Kolon-spezifisches arzneistofffreisetzungssystem
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
CN1345333A (zh) * 1999-03-03 2002-04-17 伊莱利利公司 棘白菌素/糖类复合物
AU5108200A (en) * 1999-06-09 2000-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract

Also Published As

Publication number Publication date
RU2284832C2 (ru) 2006-10-10
US20070254023A1 (en) 2007-11-01
EA010199B1 (ru) 2008-06-30
CN101031321B (zh) 2010-12-15
CN101031321A (zh) 2007-09-05
WO2006025767A8 (fr) 2007-04-05
BRPI0514708A (pt) 2008-06-24
MX2007002291A (es) 2008-02-12
TR200703565T1 (tr) 2007-08-21
EP1790357A2 (de) 2007-05-30
DE602005010280D1 (de) 2008-11-20
RU2004126203A (ru) 2006-02-10
NZ554212A (en) 2009-08-28
WO2006025767A2 (fr) 2006-03-09
ES2314708T3 (es) 2009-03-16
EA200700357A1 (ru) 2008-06-30
EP1790357B1 (de) 2008-10-08
US8231871B2 (en) 2012-07-31
CA2620919A1 (en) 2006-03-09
DK1790357T3 (da) 2009-02-02
JP5062480B2 (ja) 2012-10-31
ZA200704449B (en) 2008-08-27
AU2005280704A1 (en) 2006-03-09
PT1790357E (pt) 2008-12-31
AU2005280704B2 (en) 2010-10-07
CA2620919C (en) 2014-10-14
WO2006025767A3 (fr) 2006-08-17
EP1790357A4 (de) 2007-11-07
PL1790357T3 (pl) 2009-03-31
JP2008511622A (ja) 2008-04-17
UA85608C2 (ru) 2009-02-10

Similar Documents

Publication Publication Date Title
ATE410185T1 (de) Oral verabreichbare antimikrobielle zusammensetzung
WO2007070677A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
YU58103A (sh) Farmaceutski preparati, dozirane forme i postupci za oralnu primenu epotilona
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
WO2002043765A3 (en) Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
BR0008059A (pt) Composições de valdecoxib
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
ES2390226T3 (es) Tratamiento de enfermedades infecciosas
MA29744B1 (fr) Formulations posologiques solides de medicaments presentant une adsorption buccale amelioree
HUP0000138A2 (hu) Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények
DK0818996T3 (da) Biologisk nedbrydelige mikro- og nanosfærer med kontrolleret frigørelse, som indeholder cyclosporin
NO20062051L (no) Farmasoytisk virkestoffinneholdende formulering med belegg
WO2006021160A8 (en) Butylbenzene phthalein self-emulsifying drug delivery system, its preparation method and application
WO2005117895A8 (en) Compositions comprising meloxicam
CA2460865A1 (en) Quinoline derivatives as neuropeptide y antagonists
CA2326048A1 (en) Peroral active agent suspension
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
WO2007131070A3 (en) Compositions, dosage forms and methods of treating emesis
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
WO2008005352A3 (en) Solid dose formulations of a thrombin receptor antagonist
NO20062668L (no) Orale formuleringer av desoxypeganin og anvendelser derav
US20180250227A1 (en) Nanosuspension formulation
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
YU81101A (sh) Polimorfni oblici kristalnog citrata azabiciklo (2,2,2) oktan-3-amina i njihovih farmaceutskih kompozicija

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1790357

Country of ref document: EP